Press Releases Archives - Page 25 of 103 - Lupin

BSE 2294.55 NSE 2287.20

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2294.55 NSE 2287.20

Lupin Q4 FY2023 Results

Lupin Announces Acquisition of French Pharmaceutical Company Medisol

Lupin Diagnostics Launches Regional Reference Laboratory in Bengaluru, Strengthening Presence in South India

Lupin Receives Approval from U.S. FDA for Tenofovir Alafenamide Tablets

Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules

Lupin Announces Completion of Pharmacovigilance Inspection by the U.S. FDA with No Observations

Lupin Announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities

Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets

Lupin Receives Approval from US FDA for Brexpiprazole Tablets

Lupin’s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium Bromide Injection

1 2 … 24 25 26 … 102 103

Search

Hit enter to search or ESC to close